Pharmaceutical, biotechnology and medical products companies
August 14, 2017

Accenture Positioned as Leader and Star Performer in Everest Group 2017 Life Sciences Clinical and R&D IT Services Assessment

NEW YORK; Aug. 14, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer in a new Everest Group report on information technology (IT) service providers in the life sciences clinical and R&D industry. 
July 31, 2017

Accenture Positioned as Leader and Star Performer in Everest Group 2017 Life Sciences IT Application Services Assessment

NEW YORK; July 31, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer among 21 providers of life sciences information technology (IT) application services, in the latest Everest Group report: Life Sciences IT Applications Services – Service Provider Landscape with PEAK Matrix™ Assessment 2017. Accenture is positioned above all competitors in life sciences IT application service providers, based on its scale of operations, scope of services, investments in technology, global delivery footprint and buyer satisfaction. 
July 26, 2017

Accenture To Transform Diabetic Patient Care Using Data-driven Analytics Platform

NEW YORK; July 26, 2017 – Accenture (NYSE: ACN) is collaborating with Roche (SIX: RO, ROG; OTCQX: RHHBY) to improve how diabetes care is managed and delivered through the development of a data-driven core analytics platform for Roche’s digital diabetes ecosystem. The platform and ecosystem will seamlessly connect patients, their caregivers and healthcare providers with a suite of new digital health services. 
July 20, 2017

Accenture Completes Acquisition of LabAnswer, Expands Ability to Improve the Discovery of New Products through Accenture Scientific Laboratory Informatics

NEW YORK; July 20, 2017 – In a move to provide organizations with more comprehensive scientific informatics capabilities, Accenture (NYSE: ACN) has completed its acquisition of LabAnswer, a leading U.S.-based research and laboratory informatics technology consulting firm. 
June 26, 2017

Accenture Introduces New Analytics Capabilities in the Accenture Life Sciences Cloud for R&D

NEW YORK; June 26, 2017 – Accenture (NYSE: ACN) has developed and introduced a new analytics platform to provide real-time insights on the status and performance of clinical trials for the life sciences industry. The platform, known as the Clinical Operations Insights Platform (COIP), is a module of the Accenture Life Sciences Cloud for R&D, an industry platform for running clinical trials that deliver better patient outcomes. 
June 20, 2017

Accenture Again Positioned as a Leader in IDC MarketScape on Life Science Drug Safety Services

NEW YORK; June 20, 2017 – Accenture (NYSE: ACN) has been positioned as a “Leader” in IDC Health Insights’ recently published report, “IDC MarketScape: Worldwide Life Sciences Drug Safety Services 2017 Vendor Assessment.” 1 This is the second consecutive time Accenture has been named a Leader in the vendor assessment report, which is derived from qualitative and quantitative metrics as well as end-user feedback of drug safety service providers in the life sciences industry through the IDC MarketScape model. Click here for a link to the 2017 report. 
June 08, 2017

Accenture Calls for Applications for the HealthTech Innovation Challenge

NEW YORK; June 8, 2017 –- Accenture today announced it will continue to serve as a catalyst for identifying and engaging with emerging innovators and disruptors with the second annual Accenture HealthTech Innovation Challenge. Building on the success of the inaugural program in which 500 startups participated, the Accenture HealthTech Innovation Challenge brings together leading-edge startups with prominent health and life sciences companies to tackle some of the world’s greatest health challenges including access, affordability and transparency. 
June 01, 2017

Accenture to Acquire LabAnswer, Expanding Its Life Sciences and Cross-Industry Research and Laboratory Informatics Capabilities

NEW YORK; June 1, 2017 – Accenture (NYSE: ACN) has agreed to acquire LabAnswer, a leading U.S.-based research and laboratory informatics technology consulting firm. Terms of the acquisition were not disclosed.
April 10, 2017

Accenture and BioCelerate Collaborate to Advance Biopharmaceutical Innovation Through Increased Insights in Research & Development

NEW YORK; Apr. 10, 2017 – Accenture (NYSE:ACN) today announced it will work with BioCelerate, a subsidiary of TransCelerate BioPharma Inc., a nonprofit focused on improving efficiencies in research and development, to develop a platform enabling its member companies to aggregate and analyze preclinical and clinical information to improve drug development efficiency and bring new medicines to patients faster. 
March 17, 2017

Everest Group Names Accenture as Top Leader in the 2017 PEAK Matrix Service Provider of the Year in Healthcare and Life Sciences

CHICAGO; Mar. 17, 2017 – Accenture (NYSE: ACN) has been named by Everest Group as the top leader in the 2017 PEAK Matrix Service Provider of the Year™ in healthcare and life sciences. The designation recognizes service providers who have demonstrated consistent leadership in the PEAK Matrix™ reports issued by Everest Group in the previous year.